Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Botox Maker Allergan Sees Second Quarter Profits Jump 23 Percent

By Pharmaceutical Processing | August 3, 2009

NEW YORK (AP) — A William Blair & Co. analyst upgraded shares of Botox maker Allergan Inc. Monday, citing the company’s latest quarterly results and outlook. On Friday, Allergan said its second-quarter profit jumped 23 percent on lower costs, despite a dip in sales of the company’s cosmetic and eye care products. The results topped Wall Street forecasts. For the full year, the company expects adjusted profit between $2.71 and $2.75 per share on revenue between $4.2 billion and $4.3 billion. Analysts polled by Thomson Reuters expect full-year profit of $2.71 on revenue of $4.23 billion. Analyst Ben Andrew upgraded the stock to “Outperform” from “Market Perform” and expects the company’s eye care, medical device, and Botox units to perform well during the year. “Through this economic downturn, Allergan’s management team has retooled its operating expense structure and has entered a new era,” he wrote in a note to investors. “Uncertainties remain, and these include timing for new product approvals, competitive impact on Botox, sales impact from generic launches, and the timing of an economic recovery,” he added. “However, we feel confident management has the capabilities to work through these transitional issues, as demonstrated by the better-than-expected operating results in the past couple quarters amid the economic downturn.”

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE